LENVATINIB-LOADED POLY(LACTIC-CO-GLYCOLIC ACID) NANOPARTICLES WITH EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY CONJUGATION AS A PRECLINICAL APPROACH TO THERAPEUTICALLY IMPROVE THYROID CANCER WITH AGGRESSIVE BEHAVIOR

ENMA VERONICA PAEZ ESPINOSA

LENVATINIB-LOADED POLY(LACTIC-CO-GLYCOLIC ACID) NANOPARTICLES WITH EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY CONJUGATION AS A PRECLINICAL APPROACH TO THERAPEUTICALLY IMPROVE THYROID CANCER WITH AGGRESSIVE BEHAVIOR

ENMA VERONICA PAEZ ESPINOSA

Producción científica: Revista › Artículo › revisión exhaustiva

Idioma original	Español (Ecuador)
Publicación	REVISTA
Estado	Publicada - 13 nov. 2023

Financiación

Financiadores
Pontificia Universidad Católica del Ecuador

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

ODS 3: Salud y bienestar

Citar esto

@article{279c4df74afb42e884a9c5c4cb05491d,

title = "LENVATINIB-LOADED POLY(LACTIC-CO-GLYCOLIC ACID) NANOPARTICLES WITH EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY CONJUGATION AS A PRECLINICAL APPROACH TO THERAPEUTICALLY IMPROVE THYROID CANCER WITH AGGRESSIVE BEHAVIOR",

author = "\{PAEZ ESPINOSA\}, \{ENMA VERONICA\}",

year = "2023",

month = nov,

day = "13",

language = "Espa{\~n}ol (Ecuador)",

journal = "REVISTA",

issn = "2218-273X",

publisher = "MDPI",

}